Type your tag names separated by a space and hit enter




Common Use:
To assist in diagnosing liver disease such as hepatitis and cirrhosis and evaluating the effectiveness of treatment modalities. Also used to assist in diagnosing infant Reye’s syndrome.

Plasma collected in completely filled lavender- (EDTA) or green-top (Na or Li heparin) tube. Specimen should be transported tightly capped and in an ice slurry.

Normal Findings:
(Method: Enzymatic)

AgeConventional UnitsSI Units (Conventional Units × 0.587)
Newborn170–340 mcg/dL90–150 micromol/L
10 d–24 mo70–135 mcg/dL41–80 micromol/L
25 mo–Adult15–60 mcg/dL9–35 micromol/L


Blood ammonia (NH3) comes from two sources: deamination of amino acids during protein metabolism and degradation of proteins by colon bacteria. The liver converts ammonia in the portal blood to urea, which is excreted by the kidneys. When liver function is severely compromised, especially in situations in which decreased hepatocellular function is combined with impaired portal blood flow, ammonia levels rise. Congenital enzyme defects that prevent the breakdown of ammonia or conditions that affect the ability of the kidneys to excrete ammonia can also result in increased blood levels. Ammonia is potentially toxic to the central nervous system and may result in encephalopathy or coma if toxic levels are reached.

This procedure is contraindicated for



  • Evaluate advanced liver disease or other disorders associated with altered serum ammonia levels.
  • Identify impending hepatic encephalopathy with known liver disease.
  • Monitor the effectiveness of treatment for hepatic encephalopathy, indicated by declining levels.
  • Monitor patients receiving hyperalimentation therapy.

Potential Diagnosis

Increased In:

  • Gastrointestinal hemorrhage (related to decreased blood volume, which prevents ammonia from reaching the liver to be metabolized)
  • Genitourinary tract infection with distention and stasis (related to decreased renal excretion; levels accumulate in the blood)
  • Hepatic coma (related to insufficient functioning liver cells to metabolize ammonia; levels accumulate in the blood)
  • Inborn enzyme deficiency (evidenced by inability to metabolize ammonia)
  • Liver failure, late cirrhosis (related to insufficient functioning liver cells to metabolize ammonia)
  • Reye’s syndrome (related to insufficient functioning liver cells to metabolize ammonia)
  • Total parenteral nutrition (related to ammonia generated from protein metabolism)

Decreased In:

Critical Findings


Interfering Factors

  • Drugs and other substances that may increase ammonia levels include asparaginase, chlorothiazide, chlorthalidone, fibrin hydrolysate, furosemide, isoniazid, levoglutamide, mercurial diuretics, oral resins, thiazides, and valproic acid
  • Drugs/organisms and other substances that may decrease ammonia levels include diphenhydramine, kanamycin, monoamine oxidase inhibitors, neomycin, tetracycline, and Lactobacillus acidophilus
  • Hemolysis falsely increases ammonia levels because intracellular ammonia levels are three times higher than plasma.
  • Prompt and proper specimen processing, storage, and analysis are important to achieve accurate results. The specimen should be collected on ice; the collection tube should be filled completely and then kept tightly stoppered. Ammonia increases rapidly in the collected specimen, so analysis should be performed within 20 min of collection.

Nursing Implications Procedure

Related Studies

  • Related tests include ALT, albumin, analgesic, anti-inflammatory and antipyretic drugs (acetaminophen and acetylsalicylic acid), anion gap, AST, bilirubin, biopsy liver, blood gases, BUN, calcium, CT biliary tract and liver, CT pelvis, cystometry, cystoscopy, EGD, electrolytes, GI blood loss scan, glucose, IVP, MRI pelvis, ketones, lactic acid, Meckel’s scan, osmolality, protein, PT/INR, uric acid, and US pelvis.
  • See the Gastrointestinal, Genitourinary, and Hepatobiliary systems tables online at DavisPlus for related tests by body system.

Potential Nursing Problems

ProblemSigns & SymptomsInterventions
Confusion (related to an alteration in fluid and electrolytes, hepatic disease and encephalopathy; acute alcohol consumption; hepatic metabolic insufficiency)Disorganized thinking; restlessness; irritability; altered concentration and attention span; changeable mental function over the day; hallucinations; inability to follow directions; disoriented to person, place, time, and purpose; inappropriate affectTreat the medical condition; correlate confusion with the need to reverse altered electrolytes; evaluate medications; prevent falls and injury through use of postural support, bed alarm, or the appropriate use of restraints; consider pharmacological interventions; track accurate intake and output to assess fluid status; monitor blood ammonia level; determine last alcohol use; assess for symptoms of hepatic encephalopathy such as confusion, sleep disturbances, incoherence; protect the patient from physical harm; administer lactose as prescribed
Nutrition (related to excess alcohol intake; insufficient eating habits; altered liver function)Known inadequate caloric intake; weight loss; muscle wasting in arms and legs; stool that is pale or gray colored; skin that is flaky with loss of elasticityDocument food intake with possible calorie count; assess barriers to eating; consider using a food diary; monitor continued alcohol use, as it is a barrier to adequate protein nutrition; monitor glucose levels; monitor daily weight; perform dietary consult with assessment of cultural food selections
Skin (related to jaundice and elevated bilirubin levels; excessive scratching)Jaundiced skin and sclera; dry skin; itching skin; damage to skin associated with scratchingApply lotion to keep the skin moisturized; avoid alkaline soaps; discourage scratching; apply mittens if patient is unable to follow direction to avid scratching; administer antihistamines as ordered
Bleeding (related to alerted clotting factors; portal hypertension; esophageal bleeding)Altered level of consciousness; hypotension; increased heart rate; decreased Hgb and Hct; capillary refill greater than 3 sec; cool extremitiesIncrease frequency of vital sign assessment with variances in results; monitor for vital sign trends; administer blood or blood products as ordered; administer stool softeners as needed; encourage intake of foods rich in vitamin K; avoid foods that may irritate esophagus


  • Positively identify the patient using at least two person-specific identifiers before services, treatments, or procedures are performed.
  • Patient Teaching: Inform the patient this test can assist with the evaluation of liver function related to processing protein waste. May be used to assist in diagnosis of Reye’s syndrome in infants.
  • Obtain a history of the patient’s health concerns, symptoms, surgical procedures, and results of previously performed laboratory and diagnostic studies. Include a list of known allergens, especially allergies or sensitivities to latex.
  • Obtain a list of the patient’s current medications, including over-the-counter medications and dietary supplements (see Effects of Dietary Supplements online at DavisPlus).
  • Review the procedure with the patient. Inform the patient that specimen collection takes approximately 5 to 10 min. Address concerns about pain and explain that there may be some discomfort during the venipuncture.
  • Sensitivity to social and cultural issues, as well as concern for modesty, is important in providing psychological support before, during, and after the procedure.
  • Note that there are no food, fluid, or medication restrictions unless by medical direction.


Potential Complications:

  • Avoid the use of equipment containing latex if the patient has a history of allergic reaction to latex.
  • Instruct the patient to cooperate fully and to follow directions. Direct the patient to breathe normally and to avoid unnecessary movement.
  • Observe standard precautions, and follow the general guidelines in Patient Preparation and Specimen Collection online at DavisPlus. Positively identify the patient, and label the appropriate specimen container with the corresponding patient demographics, initials of the person collecting the specimen, date, and time of collection. Perform a venipuncture.
  • Remove the needle and apply direct pressure with dry gauze to stop bleeding. Observe/assess the venipuncture site for bleeding or hematoma formation and secure the gauze with adhesive bandage.
  • Promptly transport the specimen to the laboratory for processing and analysis. The tightly capped sample should be placed in an ice slurry immediately after collection. Information on the specimen label should be protected from water in the ice slurry by first placing the specimen in a protective plastic bag.

Post Test

  • Inform the patient that a report of the results will be made available to the requesting health-care provider (HCP), who will discuss the results with the patient.

Sensitivity to social and cultural issues, as well as concern for modesty, is important in providing psychological support before, during, and after the procedure. Recognize anxiety related to test results, and carefully observe the cirrhotic patient for the development of ascites, in which case fluid and electrolyte balance require strict attention. Dietary and fluid restrictions may be required; diuretics may be ordered. The patient should be frequently monitored for weight gain, intake and output, and abdominal girth. Patients who are alcoholics should be encouraged to avoid alcohol and also to seek appropriate counseling

  • Nutritional Considerations: Increased ammonia levels may be associated with liver disease. Dietary recommendations may be indicated, depending on the severity of the condition. A low-protein diet may be in order if the patient’s liver has lost the ability to process the end products of protein metabolism. A diet of soft foods may be required if esophageal varices have developed. Ammonia levels may be used to determine whether protein should be added to or reduced from the diet. Patients should be encouraged to eat simple carbohydrates and emulsified fats (as in homogenized milk or eggs) rather than complex carbohydrates (e.g., starch, fiber, and glycogen [animal carbohydrates]) and complex fats, which would require additional bile to emulsify them so that they could be used.
  • Depending on the results of this procedure, additional testing may be performed to evaluate or monitor progression of the disease process and determine the need for a change in therapy. Evaluate test results in relation to the patient’s symptoms and other tests performed.

Patient Education:

  • Reinforce information given by the patient’s HCP regarding further testing, treatment, or referral to another HCP.
  • Answer any questions or address any concerns voiced by the patient or family.
  • Teach the patient that small frequent meals throughout the day can increase overall caloric intake and improve nutritional status.
  • Teach the patient that scratching can damage the skin and precipitate an infection.

Expected Patient Outcomes:


  • The patient and family discuss that adherence to eating several small meals can improve caloric intake.
  • The patient and family associate compliance with taking lactulose with decreased blood ammonia level to help prevent hepatic encephalopathy.

  • The patient and family modify the diet and select foods that are appropriate for the degree of liver disease (high protein and high carbohydrate can support nutrition until liver disease prohibits these food selections).
  • The patient accurately self-administers lactulose as prescribed to reduce absorption of ammonia.

  • The patient resolves to participate in counseling for alcohol misuse.
  • The patient follows the recommendations of the HCP and family members in supporting positive health decisions.

Ammonia is a sample topic from the Davis's Lab & Diagnostic Tests.

To view other topics, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Learn more.


Bladh, Mickey Lynn., and Anne M. Van Leeuwen. "Ammonia." Davis's Lab & Diagnostic Tests, 7th ed., F.A. Davis Company, 2017. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Lab-and-Diagnostic-Tests/425026/all/Ammonia.
Bladh ML, Van Leeuwen AM. Ammonia. Davis's Lab & Diagnostic Tests. 7th ed. F.A. Davis Company; 2017. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Lab-and-Diagnostic-Tests/425026/all/Ammonia. Accessed April 22, 2019.
Bladh, M. L., & Van Leeuwen, A. M. (2017). Ammonia. In Davis's Lab & Diagnostic Tests. Available from https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Lab-and-Diagnostic-Tests/425026/all/Ammonia
Bladh ML, Van Leeuwen AM. Ammonia [Internet]. In: Davis's Lab & Diagnostic Tests. F.A. Davis Company; 2017. [cited 2019 April 22]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Lab-and-Diagnostic-Tests/425026/all/Ammonia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Ammonia ID - 425026 A1 - Bladh,Mickey Lynn, AU - Van Leeuwen,Anne M, BT - Davis's Laboratory & Diagnostic Tests UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Lab-and-Diagnostic-Tests/425026/all/Ammonia PB - F.A. Davis Company ET - 7 DB - Nursing Central DP - Unbound Medicine ER -